Merck Attacks Watson, Actavis Over Birth Control Patent

Law360, Los Angeles (July 25, 2013, 10:15 PM EDT) -- Merck & Cie and a licensee accused Watson Laboratories Inc. and Actavis Inc. of infringing Merck’s patent for birth control pill Beyaz when they applied for federal approval to manufacture a generic, according to nearly identical suits filed this week in Delaware and Nevada federal courts.

Merck and licensee Bayer HealthCare Pharmaceuticals Inc. say that the generic formula for the birth control pill proposed by the competing drugmakers is the same as the one protected by Merck-owned U.S. Patent Number 6,441,168. Merck licensed the patent to...
To view the full article, register now.